A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MISMATCH REPAIR (MMR) PROTEIN IMMUNOHISTOCHEMISTRY (IHC)
MessageNote: This test is ordered by pathology in the CoPath laboratory information system
Evaluating tumor tissue to identify patients at risk for having hereditary nonpolyposis colon cancer/Lynch syndrome. When this test is ordered,
MLH1, MSH2, MSH6, and PMS2 stains will be performed.
Evaluating tumor tissue to identify patients at risk for having hereditary nonpolyposis colon cancer/Lynch syndrome. When this test is ordered,
MLH1, MSH2, MSH6, and PMS2 stains will be performed.
Test Code
1230300890
CPT Codes
88342-TC (primary), 88341-TC (if additional IHC)
Preferred Specimen
Tissue
Methodology
Immunohistochemistry (IHC)
FDA Status
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by WVUH in a manner consistent with CLIA requirements.
Clinical Significance
Evaluating tumor tissue to identify patients at risk for having hereditary nonpolyposis colon cancer/Lynch syndrome. When this test is ordered, MLH1, MSH2, MSH6, and PMS2 stains will be performed.
Performing Laboratory
West Virginia University Hospital, Inc.